Signal Transduction Introduction PDF
Document Details
Uploaded by ExhilaratingDjinn
Tags
Summary
This document introduces signal transduction pathways, detailing the major features, origins of signals, receptor classes, and strategies for developing therapies by manipulating those pathways. It includes various diagrams of the signal transduction process.
Full Transcript
M4: L1 - Introduction Wednesday, 11 September 2024 3:00 pm LOs - Describe the major features of signal transduction pathways - Identify the four origins of a signal - Identify and compare the receptor classes involved in signal transduction - Strategise how a therapy could be d...
M4: L1 - Introduction Wednesday, 11 September 2024 3:00 pm LOs - Describe the major features of signal transduction pathways - Identify the four origins of a signal - Identify and compare the receptor classes involved in signal transduction - Strategise how a therapy could be developed for a disease by manipulating signal transduction The main steps in signal transduction ------------------------------------- ![](media/image2.png)![](media/image4.png)![](media/image6.png)![](media/image8.png)![](media/image10.png)![](media/image12.png)![](media/image14.png)![](media/image16.png)![](media/image18.png)![](media/image20.png)![](media/image22.png)![](media/image24.png)![](media/image26.png)![](media/image28.png)![](media/image30.png)![](media/image32.png)![](media/image34.png)![](media/image36.png)![](media/image38.png)![](media/image40.png)![](media/image42.png)![](media/image44.png)![](media/image46.png)![](media/image48.png)![](media/image50.png)![](media/image52.png)![](media/image54.png)![](media/image56.png)![](media/image58.png)![](media/image60.png)![](media/image62.png)![](media/image64.png)![](media/image66.png)![](media/image68.png)![](media/image70.png)![](media/image72.png)![](media/image74.png)![](media/image76.png)![](media/image78.png)![](media/image80.png)![](media/image82.png)![](media/image84.png)![](media/image86.png)![](media/image88.png)![](media/image90.png)![](media/image92.png)![](media/image94.png)![](media/image96.png)![](media/image98.png)![](media/image100.png)![](media/image102.png)![](media/image104.png)![](media/image106.png)![](media/image108.png)![](media/image110.png)![](media/image112.png)![](media/image114.png)![](media/image116.png)![](media/image118.png)![](media/image120.png)![](media/image122.png)![](media/image124.png)![](media/image126.png)![](media/image128.png)![](media/image130.png)![](media/image132.png)![](media/image134.png)![](media/image136.png) Origins of a Signal ------------------- ![](media/image138.png) - Signalling molecule (hormone) from an endocrine cell which travels through the bloodstream to a distant target cell - Classes of hormones - Peptide hormones - Amino acid hormones - Steroid hormones - can go through PM - Signalling molecules released from one cell to an adjacent cell - e.g. neuromuscular junction signalling which released Ach from synapse to muscle cells ![](media/image140.png) - Cell secretes signals which acts on the same cell - e.g. growth hormones which causes rapid growth of that cell - Signalling molecule is embedded in the membrane of signalling cell and attaches to the target cell, causing a response - e.g. antigen presenting cells, notch cells - notch signal on liver cells during development - attaches to adjacent cell so that it differentiates into the same type of cell, presenting the same signal Receptor classes ---------------- - Three distinct receptor classes involved in signal transduction with distinct properties (all expressed in cell membrane, all response to extracellular signals e.g. hormones and ligands): - G-protein coupled receptors (GPCRs) - Receptor tyrosine kinases (RTKs) - Ligand-gated ion channels (LGICs) - (Proteins that influence second-messenger synthesis - Ion channels - Proteins with intrinsic enzyme activity) ![](media/image142.png) Membrane receptors ------------------ - A receptor is a molecule on the surface of a cell - A receptor recognises a specific type of signal e.g. insulin receptor - A receptor is strategically poised to control what happens inside a cell, producing a specific effect - makes them an excellent drug target Transduction ------------ - A process by which a chemical or physical signal is transmitted through a cell as a series/cascade of molecule events (dominoes/Rube Goldberg machinery) - Relayed event - Three categories of components - Second messengers - Effector proteins - Ions - Molecules involved in signal transduction: ------------------------------------------ ### Second messengers involved in transduction - Second messengers are molecules (chemical signals) inside cells that act to transmit signals from a receptor to a target i.e. they are free to move/diffuse in the cell - not attached to membrane - (cause a relay of signals) - Types of second messengers: ![](media/image144.png) ### Effector proteins - Effector proteins are molecules (often, enzymes) inside a cell that further transduce a signal - End result of many signal transductions is the phosphorylation (phos) of dephosphorylation (dephos) of target proteins - Examples: - Kinases - phosphorylate downstream molecules, often results in phosphorylation cascades - Adenylate cyclase (AC) - produces cAMP (secondary messengers) from ATP - Phospholipase - hydrolyses phospholipids ### Ion channels (part of LGIC) - Ion concentration within a cell play important role in maintaining homeostasis and regulate many physiological functions e.g. neural communication, muscle contraction, cell proliferation, osmotic stability, etc. - Neural - Na+, K+ - Muscle - Ca2+ - Apoptosis - Cl-, K+, Ca2+ Amplification ------------- - How a small amount of signalling molecule can lead to a fast and efficient response - Every step of transduction pathway post-signal binding leads to multiple resulting messengers \--\> ends with a really amplified response ![](media/image146.png) - This graph shows that as ligand conc. increases, fraction of ligand bound to receptors increases and physiological response increases - But, when only 50% of ligands bind to their surface receptor, almost a max physiological response occurs (80%) - So only a small number of ligands need to bind to their receptor to get a large physiological response due to amplification of signal from the small number of ligands Response and Regulation ----------------------- - If response is not regulated/turned off, overstimulation of signal transduction pathway leading to too much response AND cannot respond to subsequent signals - Once the desired response is achieved, signal transduction pathway needs to be regulated and terminated so system can be sensitive to further stimulation - (details of regulation for diff receptor types discussed in future lectures) Drug development strategies --------------------------- - If you get a disease - some part of signal transduction has gone wrong (usually, the signal) - e.g. diabetes - not enough insulin signal to cause uptake of glucose into cells - From this, we can design therapies to increase insulin production or provide body with insulin - If the response is something we want to happen, we can design drugs to target any step of signal transduction to increase the response (inc. signal, reception, transduction, dec. regulation) ![](media/image148.png) - Most of the known human therapeutic drugs target receptors - Many of these are GPCRs because GPCRs are found in many different system so they are a target by many drugs for many different conditions Signal Transduction in Drug Discovery Lab ----------------------------------------- ![](media/image150.png) - Lab is looking at potential migraine drugs - can be a novel drug or existing drugs used for other conditions - The CGRP receptor is known to cause increased pain and migraines - so need to inhibit this receptor - Develop a signal which will inhibit this receptor (antagonist) and blocks signalling pathway - prevent signalling molecule from binding and causing a signal transduction pathway, leading to increased pain and migraines - Two types of signals: - Small molecule - Antibody - Effect of drugs can be measured using the pain scale or looking for a change in concentration of the intracellular secondary messenger upon taking the drug - If drug inc. amount of secondary messengers \--\> increased response (pain and migraines) - drug is ineffective Summary ======= Major features of ST pathways ----------------------------- - Signal - Four major cell communication methods - Endocrine - Paracrine - Autocrine - Plasma-membrane attached signalling - Reception - Transduction - Second messengers - cAMP, IP3, DAG - Ions - Ca2+, Na+, K+, Cl- - Effectors - kinase, AC, phospholipase - Amplification - larger physiological response - Regulation + Response - to turn off - Three classes of receptors - GPCR - RTK - LGIC - Lab - drug discovery - LAQ e.g. at start of L2 SIGNAL ------ ![](media/image152.png) Cell-surface hormones (main focus of this module) ![](media/image154.png) ![](media/image156.png) ![](media/image158.png)![](media/image160.png)![](media/image162.png)![](media/image164.png)![](media/image166.png)![](media/image168.png)![](media/image170.png)![](media/image172.png)![](media/image174.png)![](media/image176.png)![](media/image178.png) RECEPTION --------- ![](media/image180.png)![](media/image182.png)![](media/image184.png)![](media/image186.png)![](media/image188.png)![](media/image190.png)![](media/image192.png)![](media/image194.png)![](media/image196.png)![](media/image198.png) ![](media/image200.png)![](media/image202.png)![](media/image204.png)![](media/image206.png) ![](media/image208.png)![](media/image210.png)![](media/image212.png)![](media/image214.png)![](media/image216.png)![](media/image218.png)![](media/image220.png)![](media/image222.png) ![](media/image224.png) TRANSDUCTION ------------ ![](media/image226.png)![](media/image228.png)![](media/image230.png)![](media/image232.png)![](media/image234.png)![](media/image236.png)![](media/image238.png)![](media/image240.png)![](media/image242.png) ![](media/image244.png) cAMP/cGMP Calcium ion Inositol 1,4,5-triphosphate (IP3) Diacylglycerol (DAG) ![](media/image246.png)![](media/image248.png)![](media/image250.png)![](media/image252.png)![](media/image254.png)![](media/image256.png)![](media/image258.png)![](media/image260.png)![](media/image262.png) ![](media/image264.png)![](media/image266.png)![](media/image268.png)![](media/image270.png)![](media/image272.png)![](media/image274.png)![](media/image276.png)![](media/image278.png)![](media/image280.png)![](media/image282.png)![](media/image284.png)![](media/image286.png)![](media/image288.png)![](media/image290.png)![](media/image292.png)![](media/image294.png)![](media/image296.png)![](media/image298.png)![](media/image300.png)![](media/image302.png)![](media/image304.png)![](media/image306.png)![](media/image308.png)![](media/image310.png)![](media/image312.png)![](media/image314.png)![](media/image316.png)![](media/image318.png)![](media/image320.png)![](media/image322.png)![](media/image324.png)![](media/image326.png)![](media/image328.png)![](media/image330.png)![](media/image332.png)![](media/image334.png)![](media/image336.png)![](media/image338.png)![](media/image340.png)![](media/image342.png)![](media/image344.png)![](media/image346.png)![](media/image348.png)![](media/image350.png)![](media/image352.png)![](media/image354.png)![](media/image356.png)![](media/image358.png)![](media/image360.png)![](media/image362.png)![](media/image364.png)![](media/image366.png)![](media/image368.png)![](media/image370.png)![](media/image372.png) ![](media/image374.png)![](media/image376.png)![](media/image378.png)![](media/image380.png)![](media/image382.png)![](media/image384.png)![](media/image386.png)![](media/image388.png)![](media/image390.png)![](media/image392.png)![](media/image394.png)![](media/image396.png)![](media/image398.png)![](media/image400.png)![](media/image402.png)![](media/image404.png)![](media/image406.png)![](media/image408.png)![](media/image410.png)![](media/image412.png)![](media/image414.png) ![](media/image416.png)![](media/image418.png) (don't know how drug works) ![](media/image420.png) ![](media/image422.png)![](media/image424.png)![](media/image426.png)![](media/image428.png) ![](media/image430.png)![](media/image432.png)![](media/image434.png)![](media/image436.png)![](media/image438.png)![](media/image440.png)![](media/image442.png)![](media/image444.png)![](media/image446.png)![](media/image448.png)![](media/image450.png)![](media/image452.png)![](media/image454.png)![](media/image456.png)![](media/image458.png)![](media/image460.png)![](media/image462.png)![](media/image464.png)![](media/image466.png)![](media/image468.png)![](media/image470.png)![](media/image472.png)![](media/image474.png)![](media/image476.png)![](media/image478.png)![](media/image480.png)![](media/image482.png)